Patent US4900552A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4900552A Expired / Lapsed US ⏱️ 0.0 years remaining

Mucoadhesive buccal dosage forms

Assignee: Actavis Laboratories UT Inc
•
Filing: 1988-03-30
•
Granted: 1990-02-13
•
Expires: 2008-03-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A trilaminate film suitable for prolonged and sustained delivery of an active ingredient in a buccal cavity is disclosed. A hydratable mucoadhesive base layer, a non-adhesive reservoir layer and a water-impermeable carrier film sandwiched between and bonded to the base layer and the reservoir layer are the elements which form the trilaminate film.

Inventors

  • 👤 Dilip R. Sanvordeker
  • 👤 Sau-Hung S. Leung

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 03:00
CPC Classifications
A; A61; A61Q; A61Q11/00; A61K; A61K8/00; A61K8/02; A61K8/0208; A61K9/00; A61K9/0012; A61K9/0053; A61K9/006

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 75 words
A buccal dosage form suitable for delivery of an active ingredient in a buccal cavity and comprising: a hydratable mucoadhesive base layer; a non-adhesive reservoir layer; and a water-impermeable barrier sandwiched between and bonded to said base layer and said reservoir layer; said reservoir layer comprising a plasticized filmforming cellulose ester, a dehydrated hydrogel and said active ingredient to be dispersed directly into the buccal cavity; and said water-impermeable barrier comprising a cellulose ester film.
Claim 2
Dependent Claim 75 words
A buccal dosage form suitable for delivery of an active ingredient in a buccal cavity and comprising: a hydratable mucoadhesive base layer; a non-adhesive reservoir layer; and a water-impermeable barrier sandwiched between and bonded to said base layer and said reservoir layer; said reservoir layer comprising a plasticized filmforming cellulose ester, a dehydrated hydrogel and said active ingredient to be dispersed directly into the buccal cavity; and said water-impermeable barrier comprising a cellulose ester film.
Claim 3
Dependent Claim 45 words
The buccal dosage form in accordance with claim 1 wherein the mucoadhesive base layer is constituted by a member of the group consisting of water-swellable, but water-insoluble, fibrous, cross-linked carboxy-functional polymers, hydrophilic polysaccharide gums, cross-linked alignate gum gels, water-dispersible polycarboxylated vinyl polymers, and mixtures thereof.
Claim 4
Dependent Claim 30 words
The buccal dosage form in accordance with claim 2 wherein the hydrophilic polysaccharide gum is a member of the group consisting of a natural plant exudate and a seed gum.
Claim 5
Dependent Claim 37 words
The buccal dosage form in accordance with claim 2 wherein the hydrophilic polysaccharide gum is a member of the group consisting of karaya gum, ghatti gum, locust bean gum, guar gum, psillium seed gum and mixtures thereof.
Claim 6
Dependent Claim 32 words
The buccal dosage form in accordance with claim 1 wherein the cellulose ester film is a member of the group comprising of cellulose acetate butyrate, cellulose acetate isobutyrate, and cellulose acetate propionate.
Claim 7
Dependent Claim 34 words
The buccal dosage form in accordance with claim 1 wherein the weight ratio of cellulose ester to dehydrated hydrogel in the reservoir layer is in the range of about 7:3 to about 1:4, respectively.
Claim 8
Dependent Claim 34 words
The buccal dosage form in accordance with claim 1 wherein the weight ratio of cellulose ester to dehydrated hydrogel in the reservoir layer is in the range of about 6:4 to about 1:3, respectively.
Claim 9
Dependent Claim 23 words
The buccal dosage form in accordance with claim 1 wherein the hydrogel is a combination of a polyoxyalkylene block copolymer and alginic acid.
Claim 10
Dependent Claim 27 words
The buccal dosage form in accordance with claim 8 wherein the weight ratio of polyoxyalkylene block copolymer to alginic acid is about 5 to about 0.2, respectively.
Claim 11
Dependent Claim 28 words
The buccal dosage form in accordance with claim 8 wherein the polyoxyalkylene block copolymer contains oxyethylene chains and oxypropylene chains in a weight ratio of about 7:3, respectively.

References Cited (Backward Citations)

US307537A Cited
US3598122A Cited
US3598122B1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-02-12 1993-08-14 1994-02-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-02-12 1997-08-14 1998-02-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-02-12 2001-08-14 2002-02-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag